Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 3, 2023
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
Salveen Richter Maintained (AGIO) at Hold with Decreased Target to $28 on, Nov 3rd, 2023
Salveen Richter of Goldman Sachs, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Hold with Decreased Target from $32 to $28 on, Nov 3rd, 2023.
Salveen has made no other calls on AGIO in the last 4 months.
There is 1 other peer that has a rating on AGIO. Out of the 1 peers that are also analyzing AGIO, all agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tessa Romero of "JP Morgan" Maintained at Hold with Decreased Target to $32 on, Monday, August 7th, 2023
